FDA.reportPublic FDA data

carbidopa 87.5 MG / L-DOPA 350 MG Extended Release Oral Capsule [Crexont]

RxCUI
2690292
RxNorm name
carbidopa 87.5 MG / L-DOPA 350 MG Extended Release Oral Capsule [Crexont]
Display name
carbidopa 87.5 MG / L-DOPA 350 MG Extended Release Oral Capsule [Crexont]
Full name
carbidopa 87.5 MG / L-DOPA 350 MG Extended Release Oral Capsule [Crexont]
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CREXONTCARBIDOPA AND LEVODOPAAmneal Pharmaceuticals LLC095a08b6-b0b8-4f88-b759-67e8b87287a02026-05-29Warnings, Adverse reactionsExact identifier
rxcui: 2690292

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
095a08b6-b0b8-4f88-b759-67e8b87287a0CREXONT 87.5 MG / 350 MG Extended Release Oral Capsule [PSN] · carbidopa 87.5 MG / levodopa 350 MG Extended Release Oral Capsule [Crexont] [SBD] · carbidopa 87.5 MG / L-DOPA 350 MG Extended Release Oral Capsule [Crexont] [SY] · Crexont (carbidopa 87.5 MG / levodopa 350 MG) Extended Release Oral Capsule [SY]419These highlights do not include all the information needed to use CREXONT ® safely and effectively. See full prescribing information for CREXONT . CREXONT ® ( carbidopa and levodopa ) extended-release capsules, for oral use Initial U.S. Approval: 197520260529